Tomlinson, B., de Lima, M., Cogle, C. R., Thompson, M. A., Grinblatt, D. L., Pollyea, D. A., … Scott, B. L. (2020). Transplant Referral Patterns for Patients (Pts) with Newly Diagnosed (ND) Higher-Risk (HR) Myelodysplastic Syndromes (MDS), and European Leukemianet (ELN) 2010 Intermediate-Risk (IR) or Adverse-Risk (AR) Acute Myeloid Leukemia (AML) in the Connect (R) MDS/AML Registry. In BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (Vol. 26, pp. S98–S98). Orlando, FL: ELSEVIER SCIENCE INC.

Tomlinson, Benjamin, Marcos de Lima, Christopher R. Cogle, Michael A. Thompson, David L. Grinblatt, Daniel A. Pollyea, Rami Komrokji, et al. “Transplant Referral Patterns for Patients (Pts) with Newly Diagnosed (ND) Higher-Risk (HR) Myelodysplastic Syndromes (MDS), and European Leukemianet (ELN) 2010 Intermediate-Risk (IR) or Adverse-Risk (AR) Acute Myeloid Leukemia (AML) in the Connect (R) MDS/AML Registry.” In BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26:S98–S98. ELSEVIER SCIENCE INC, 2020.

Tomlinson B, de Lima M, Cogle CR, Thompson MA, Grinblatt DL, Pollyea DA, et al. Transplant Referral Patterns for Patients (Pts) with Newly Diagnosed (ND) Higher-Risk (HR) Myelodysplastic Syndromes (MDS), and European Leukemianet (ELN) 2010 Intermediate-Risk (IR) or Adverse-Risk (AR) Acute Myeloid Leukemia (AML) in the Connect (R) MDS/AML Registry. In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC; 2020. p. S98–S98.

Tomlinson, Benjamin, et al. “Transplant Referral Patterns for Patients (Pts) with Newly Diagnosed (ND) Higher-Risk (HR) Myelodysplastic Syndromes (MDS), and European Leukemianet (ELN) 2010 Intermediate-Risk (IR) or Adverse-Risk (AR) Acute Myeloid Leukemia (AML) in the Connect (R) MDS/AML Registry.” BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 26, no. 3, ELSEVIER SCIENCE INC, 2020, pp. S98–S98.

Tomlinson B, de Lima M, Cogle CR, Thompson MA, Grinblatt DL, Pollyea DA, Komrokji R, Roboz GJ, Savona MR, Sekeres MA, Flick ED, Kiselev P, Louis CU, Nifenecker M, Swern AS, Erba HP, Steensma DP, Scott BL. Transplant Referral Patterns for Patients (Pts) with Newly Diagnosed (ND) Higher-Risk (HR) Myelodysplastic Syndromes (MDS), and European Leukemianet (ELN) 2010 Intermediate-Risk (IR) or Adverse-Risk (AR) Acute Myeloid Leukemia (AML) in the Connect (R) MDS/AML Registry. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC; 2020. p. S98–S98.